Serina Therapeutics

Serina Therapeutics pioneers polymer therapeutics and drug delivery platforms. Their mission is to develop innovative treatments for neurological diseases and other indications using their proprietary POZ platform technology, which enables programmable, targeted delivery of small molecules, proteins, and other therapeutic agents. They focus on addressing unmet medical needs, particularly in CNS disorders like Parkinson’s disease, and collaborate with partners to advance RNA medicines, cancer immunotherapy, and gene therapy.